Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
COOP

Mr. Cooper

$1.30

-0.03 (-2.26%)

, CVM

CEL-SCI

$3.70

-0.125 (-3.27%)

08:30
10/11/18
10/11
08:30
10/11/18
08:30
Options
Six new option listings and two option delistings on October 11th »

New option listings for…

COOP

Mr. Cooper

$1.30

-0.03 (-2.26%)

CVM

CEL-SCI

$3.70

-0.125 (-3.27%)

GTX

Garrett Motion

$15.70

-0.55 (-3.38%)

NINE

Nine Energy Services

$33.45

-1.31 (-3.77%)

QTT

Qutoutiao

$7.18

-0.47 (-6.14%)

RARX

RA Pharmaceuticals

$15.09

0.52 (3.57%)

GPT

Acquired by BX

$27.49

(0.00%)

WMIH

WMIH

$1.30

-0.03 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$14.57

-0.83 (-5.39%)

, ALXN

Alexion

$130.61

1.15 (0.89%)

07:46
10/10/18
10/10
07:46
10/10/18
07:46
Upgrade
RA Pharmaceuticals, Alexion rating change  »

RA Pharmaceuticals…

RARX

RA Pharmaceuticals

$14.57

-0.83 (-5.39%)

ALXN

Alexion

$130.61

1.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 18

    Feb

RARX

RA Pharmaceuticals

$14.57

-0.83 (-5.39%)

05:58
10/10/18
10/10
05:58
10/10/18
05:58
Upgrade
RA Pharmaceuticals rating change at Raymond James »

RA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$15.50

-0.62 (-3.85%)

07:34
09/26/18
09/26
07:34
09/26/18
07:34
Hot Stocks
RA Pharmaceuticals announces results from Phase 1b study of zilucoplan »

Ra Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Over a month ago
RARX

RA Pharmaceuticals

$11.99

-0.19 (-1.56%)

07:36
09/05/18
09/05
07:36
09/05/18
07:36
Hot Stocks
RA Pharmaceuticals completes Phase 2 FDA interactions, designs Phase 3 program »

Ra Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$10.94

0.22 (2.05%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

RARX

RA Pharmaceuticals

$10.94

0.22 (2.05%)

13:23
08/14/18
08/14
13:23
08/14/18
13:23
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

RARX

RA Pharmaceuticals

$11.01

0.9 (8.90%)

11:44
08/08/18
08/08
11:44
08/08/18
11:44
Recommendations
RA Pharmaceuticals analyst commentary at Raymond James »

RA Pharmaceuticals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$10.11

0.28 (2.85%)

07:22
08/08/18
08/08
07:22
08/08/18
07:22
Earnings
RA Pharmaceuticals reports Q2 EPS (49c), consensus (55c) »

"Enthusiasm from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
RARX

RA Pharmaceuticals

$10.93

0.49 (4.69%)

08:24
07/20/18
07/20
08:24
07/20/18
08:24
Initiation
RA Pharmaceuticals initiated at BMO Capital »

RA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.